Pfizer ‘seeking approval from Hong Kong officials to introduce RSV vaccine’, as experts say jab could help protect high-risk groups
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
American pharmaceutical giant filed application for regulatory approval of its Abrysvo jab in Hong Kong last month, source familiar with situation says.